SAFEST
Phase 1
- Conditions
- Ischemic stroke or transient ischemic attackTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Registration Number
- CTIS2022-502059-79-00
- Lead Sponsor
- Amsterdam UMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 1200
Inclusion Criteria
Age = 70 years or older at the time of ischemic stroke or TIA; inclusion within 6 weeks after diagnosis of ischemic stroke or TIA; frailty as defined by a pre-event score of 4-7 and/or post-event score of 6-7 on the validated Clinical Frailty Scale.
Exclusion Criteria
Very severe frailty or very limited life expectancy (< 6 months) as defined by a score >= 8 points on the validated Clinical Frailty Scale; a previous serious adverse drug reaction to statins; not speaking Dutch; being unable to answer questions and have no proxy assessment available; being unable or not willing to give written informed consent (either patient or patient with help from proxy).
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method